GL1X · GenesisL1 explorer

MolNFT v1 · #103372 · protein

Crystal structure of a trap periplasmic solute binding protein from colwellia psychrerythraea (CPS_0129, target efi-510097) with bound calcium and pyruvate

4PET · Extracellular solute-binding protein, family 7: “Crystal structure of a trap periplasmic solute binding protein from colwellia psychrerythraea (CPS_0129…”. X-ray diffraction, 3 ligands (PYR, CA, CL), 5 pockets (best druggability…

PDB
4PET
Type
protein
Length
657 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Extracellular solute-binding protein, family 7
UniProt
Q48AL6
Ligands
PYR, CA, CL
Pockets
5 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 55% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AExtracellular solute-binding protein, family 7protein32954% helix, 15% strandQ48AL6
BExtracellular solute-binding protein, family 7protein32855% helix, 15% strandQ48AL6

Ligands and binding sites

  • PYR · Pyruvic acid · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11080.560.8425empty
21050.520.8223empty
32130.500.7527empty
41780.500.7726empty
51990.480.7527empty

Interfaces

1 interface between chains.

  • A–B · 2883 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 38 modified (engineered).

Compared structures

  • 4PET · Crystal structure of a trap periplasmic solute binding protein from colwellia… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.